Table 5.
Females | Males | Total | ||||
---|---|---|---|---|---|---|
Interview and testing status | N | Prevalence [95% CI] | N | Prevalence [95% CI] | Total | Prevalence [95% CI] |
Interviewed & Tested-Observed prevalence (a) | 1713 | 12.43 [10.87-14.00] | 1008 | 09.82 [07.98-11.66] | 2721 | 11.47 [10.27-12.67] |
Interviewed only-imputed prevalence (b) | 363 | 11.93 [10.89-13.03] | 210 | 8.95 [7.77-10.26] | 573 | 10.84 [10.04-11.67] |
Refused both-imputed prevalence (c) | 142 | 10.07 [8.55-11.75] | 61 | 9.34 [7.15-11.94] | 203 | 9.85 [8.59-11.23] |
No contact made-imputed prevalence (d) | 713 | 11.78 [11.04-12.55] | 557 | 10.43 [9.64-11.26] | 1270 | 11.19 [10.65-11.75] |
Imputed prevalence all non-response -imputed prevalence-b,c & d (e) | 1218 | 11.63 [9.86-13.46] | 828 | 9.97 [7.97-12.07] | 2046 | 10.96 [9.6-12.30] |
Overall, corrected prevalence-adjusted (f) | 2931 | 12.10 [10.93-13.29] | 1836 | 9.89 [8.54-11.28] | 4767 | 11.25 [10.34-12.14] |
Ratio (e/a) | 0.94 | 1.02 | 0.96 | |||
Ratio (f/a) | 0.97 | 1.01 | 0.98 |